Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
- Status
- UNKNOWN
- Phase
- N/A
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Protocole Advanced RadioTherapy ORL
- Status
- COMPLETED
- Phase
- N/A
Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early Detection, and Physical Therapy Intervention
- Status
- UNKNOWN
- Phase
- NA
Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis
- Status
- TERMINATED
- Phase
- PHASE1
NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
- Status
- COMPLETED
- Phase
- PHASE3
Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
- Status
- TERMINATED
- Phase
- PHASE2
Oral Rigosertib for Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy
- Status
- COMPLETED
- Phase
- NA
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
The Head and Neck Tumor Biobank
- Status
- COMPLETED
- Phase
- N/A
Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2